Renaissance Technologies increased its stake in Enlivex Therapeutics, which is listed on the NASDAQ stock exchange.
4 reports, 1 independent
Updated Sep 2
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Renaissance Technologies increased its stake in Enlivex Therapeutics, which is listed on the NASDAQ stock exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Renaissance Technologies reduces holdings in Enlivex Therapeutics; MarketBeat rating update.1 source
Renaissance increased its stake in Enlivex Therapeutics, a company listed on NASDAQ.1 source
Keep exploring
The entities involved
-
Renaissance Technologies
American hedge fund firm
-
Nasdaq
American fully electronic stock exchange
Related events
- Renaissance Technologies acquired shares listed on Nasdaq on August 16, 2026.
- Renaissance Technologies raised its stake in shares of Star Equity Holdings, Inc. on August 25, 2026.
- Renaissance Technologies increased its stake in Bolt Biotherapeutics, a company listed on Nasdaq and filing with the SEC.
- Pulmonx Corporation is listed on Nasdaq, and Renaissance Technologies and Bank of America Corp DE increased their holdings in the company.
- Renaissance Technologies has purchased a new stake in Adlai Nortye Ltd., a company whose shares are traded on the electronic stock exchange.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- dailypolitical.comShort Interest in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Declines By 98.2%